Goldstein FC - Search Results

1

A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.

Steenland K, Zhao L, John SE, Goldstein FC, Levey A, Alvaro A; Alzheimer’s Disease Neuroimaging Initiative. Steenland K, et al. Among authors: goldstein fc. J Alzheimers Dis. 2018;63(4):1383-1393. doi: 10.3233/JAD-170769. J Alzheimers Dis. 2018. PMID: 29843232 Free PMC article.

2

Treatment trial of oxiracetam in Alzheimer's disease.

Green RC, Goldstein FC, Auchus AP, Presley R, Clark WS, Van Tuyl L, Green J, Hersch SM, Karp HR. Green RC, et al. Among authors: goldstein fc. Arch Neurol. 1992 Nov;49(11):1135-6. doi: 10.1001/archneur.1992.00530350049018. Arch Neurol. 1992. PMID: 1444879 Clinical Trial.

3

Source memory in mild to moderate Alzheimer's disease.

Goldman WP, Winograd E, Goldstein FC, O'Jile J, Green RC. Goldman WP, et al. Among authors: goldstein fc. J Clin Exp Neuropsychol. 1994 Feb;16(1):105-16. doi: 10.1080/01688639408402621. J Clin Exp Neuropsychol. 1994. PMID: 8150881

4

The mere exposure effect in patients with Alzheimer's disease.

Winograd E, Goldstein FC, Monarch ES, Peluso JP, Goldman WP. Winograd E, et al. Among authors: goldstein fc. Neuropsychology. 1999 Jan;13(1):41-6. doi: 10.1037//0894-4105.13.1.41. Neuropsychology. 1999. PMID: 10067774

5

Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.

Goldstein FC, Ashley AV, Gearing M, Hanfelt J, Penix L, Freedman LJ, Levey AI. Goldstein FC, et al. Neurology. 2001 Nov 27;57(10):1923-5. doi: 10.1212/wnl.57.10.1923. Neurology. 2001. PMID: 11723294

6

Hypertension and cognitive performance in African Americans with Alzheimer disease.

Goldstein FC, Ashley AV, Freedman LJ, Penix L, Lah JJ, Hanfelt J, Levey AI. Goldstein FC, et al. Neurology. 2005 Mar 8;64(5):899-901. doi: 10.1212/01.WNL.0000152888.26576.37. Neurology. 2005. PMID: 15753433

7

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D. Levey A, et al. Clin Ther. 2006 Jul;28(7):991-1001. doi: 10.1016/j.clinthera.2006.07.006. Clin Ther. 2006. PMID: 16990077 Review.

8

Daytime sleepiness and functional impairment in Alzheimer disease.

Lee JH, Bliwise DL, Ansari FP, Goldstein FC, Cellar JS, Lah JJ, Levey AI. Lee JH, et al. Among authors: goldstein fc. Am J Geriatr Psychiatry. 2007 Jul;15(7):620-6. doi: 10.1097/JGP.0b013e3180381521. Am J Geriatr Psychiatry. 2007. PMID: 17586786

9

Development of a rapid screening instrument for mild cognitive impairment and undiagnosed dementia.

Steenland NK, Auman CM, Patel PM, Bartell SM, Goldstein FC, Levey AI, Lah JJ. Steenland NK, et al. Among authors: goldstein fc. J Alzheimers Dis. 2008 Nov;15(3):419-27. doi: 10.3233/jad-2008-15308. J Alzheimers Dis. 2008. PMID: 18997295 Free PMC article.

10

Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease.

Goldstein FC, Ashley AV, Endeshaw YW, Hanfelt J, Lah JJ, Levey AI. Goldstein FC, et al. Alzheimer Dis Assoc Disord. 2008 Oct-Dec;22(4):336-42. doi: 10.1097/wad.0b013e318188e80d. Alzheimer Dis Assoc Disord. 2008. PMID: 19068499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page